← Open Payments lookup

FLORA DIAMREYAN: Open Payments

NPI 1477626521 · RANCHO CUCAMONGA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,748 in 121 payments from 14 companies in 2025. Trend: 2023 $1,999 · 2024 $2,067 · 2025 $2,748

Food & beverage: $2,748
CompanyPaymentsAmount
Alkermes, Inc.15$576
ABBVIE INC.24$411
Axsome Therapeutics, Inc.11$285
Janssen Pharmaceuticals, Inc11$258
Neurocrine BioSciences, Inc.11$244
Supernus Pharmaceuticals, Inc.13$203
E.R. Squibb & Sons, L.L.C.9$200
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$198
Teva Pharmaceuticals USA, Inc.6$122
Vanda Pharmaceuticals Inc.4$105

Products named: ARISTADA, VRAYLAR, Auvelity, INGREZZA, INVEGA SUSTENNA, Qelbree, CAPLYTA, COBENFY.

Industry payments across CA — which companies pay providers there.